“성수동오피┎여자많은┚여탑 〔 YEOTOP2.COM 〕성수동휴게텔✃성수동오피∵성수동안마ⅱ성수동립카페ふ성수동스파☢성수동키스방”的搜索结果，显示 71-80 项，共有 2421 项

1. 神经科- 临床试验- 妙佑医疗国际

   ... (2) improves stroke outcomes at 3 months in patients who experienced an ischemic stroke. Cerebrospinal Fluid (CSF) Biomarkers for Prediction of Dementia.

2. 神经科- 临床试验- 妙佑医疗国际

   This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may ...

3. 神经科- 临床试验- 妙佑医疗国际

   ... (2) early onset non-Alzheimer's Disease (EO-nonAD) participants,and (3) cognitively normal (CN) control participants. A Study of Nivolumab and Multi-fraction ...

4. 神经科- 临床试验- 妙佑医疗国际

   This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may have ...

5. 泌尿科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to assess the differences in microvascular anastomosis outcomes between the experiment aneurysmal subarachnoid ...

6. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

7. 神经科- 临床试验- 妙佑医疗国际

   ... (2) early onset non-Alzheimer's Disease (EO-nonAD) participants,and (3) cognitively normal (CN) control participants. A Study of Nivolumab and Multi-fraction ...

8. 神经科- 临床试验- 妙佑医疗国际

   Jacksonville, Fla. The purpose of this study is to evaluate the safety, pharmacokinetics and biodistribution of an imaging agent, 18F-OP-801 (18F Hydroxyl ...

9. 神经科- 临床试验- 妙佑医疗国际

   ... (2) early onset non-Alzheimer's Disease (EO-nonAD) participants,and (3) cognitively normal (CN) control participants. A Study to Develop Liquid Biopsy for ...

10. 神经科- 临床试验- 妙佑医疗国际

    The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...